Core Viewpoint - Hunan Yichuang Health Management Co., Ltd. has been established with a registered capital of 2 million RMB, fully owned by Hunan Yichuang Medical Technology Co., Ltd. [1] Group 1: Company Overview - The legal representative of Hunan Yichuang Health Management Co., Ltd. is Li Longyan [1] - The company is classified under the scientific research and technical service industry, specifically in research and experimental development [1] - The registered address is located at No. 11, Yanggao Road, Lugu Street, Xiangjiang New District, Hunan [1] Group 2: Business Scope - The business scope includes food sales, internet food sales, medical research and experimental development, remote health management services, and health consulting services (excluding diagnostic services) [1] - The company is also involved in the sale of first and second-class medical devices, import and export agency, technology import and export, and sales of disinfectants and daily chemical products [1] - Additional activities include retail and wholesale of cosmetics, personal hygiene products, health food (pre-packaged), and daily necessities [1]

Core Viewpoint - Shenzhen Lidao Pharmaceutical Technology Co., Ltd. has been established with a registered capital of 10 million RMB, fully owned by Shanghai Lidao Pharmaceutical Technology Co., Ltd. [1] Company Overview - The legal representative of Shenzhen Lidao Pharmaceutical Technology Co., Ltd. is Wang Youxin [1] - The company is classified under the scientific research and technical service industry, specifically in research and experimental development [1] - The registered address is located at 112 Qingshuihe Road, Building 1, Room 1501, Shenzhenshi Luohu District [1] Shareholding Structure - Shanghai Lidao Pharmaceutical Technology Co., Ltd. holds 100% of the shares in Shenzhen Lidao Pharmaceutical Technology Co., Ltd. [1] Business Scope - The business scope includes general projects such as medical research and experimental development, engineering and technical research, and scientific research [1] - The company is involved in the manufacturing and sales of laboratory analysis instruments, drug testing instruments, and pharmaceutical specialized equipment [1] - The company also engages in technology services, development, consulting, and transfer, as well as the sale of specialized chemical products and basic chemical raw materials [1]

Core Viewpoint - Tianjin Meiji Biopharmaceutical Technology Co., Ltd. has been established with a registered capital of 10 million RMB, fully owned by Shanghai Meiji Biopharmaceutical Technology Co., Ltd. [1] Company Overview - The legal representative of Tianjin Meiji Biopharmaceutical Technology Co., Ltd. is Huang Huasheng [1] - The company is classified under the scientific research and technical service industry, specifically in engineering and technical research and experimental development [1] - The registered address is Room 101, No. 6 Factory, New Creation Road, Core Area of Jingjin Industrial City, Wuqing Development Zone, Tianjin [1] - The company type is a limited liability company (sole proprietorship) with an operating period until February 13, 2026, with no fixed term thereafter [1] Shareholding Structure - Shanghai Meiji Biopharmaceutical Technology Co., Ltd. holds 100% of the shares in Tianjin Meiji Biopharmaceutical Technology Co., Ltd. [1] Business Scope - The business scope includes technical services, development, consulting, communication, transfer, and promotion; medical research and experimental development; manufacturing of specialized chemical products (excluding hazardous chemicals); import and export of goods and technology; sales of specialized chemical products (excluding hazardous chemicals); conference and exhibition services (subject to approval for overseas exhibitions); sales of mechanical and electronic products [1] - The company is also authorized to conduct second-class value-added telecommunications business, subject to approval by relevant authorities [1]

Group 1 - The core point of the article is the establishment of Tianjin He Yi New Energy Co., Ltd., with a registered capital of 100 million RMB, fully owned by Shenzhen Jing Shan New Materials Co., Ltd. [1] Group 2 - The legal representative of Tianjin He Yi New Energy Co., Ltd. is Wang Jingyu [1] - The company operates in various sectors including energy management services, sales of metal products, and technology development [1] - The registered address of the company is in the Tianjin Free Trade Zone, specifically at No. 18 Guomao Road, Tengda Building, Room 309 [1] - The company is classified under the national standard industry of scientific research and technical services, specifically in engineering and technical research and experimental development [1] - The business license allows the company to operate independently, except for projects that require approval [1]

Group 1 - The core point of the article is the establishment of Jianxiaoxiang Health Technology (Shenzhen) Co., Ltd., which is fully owned by Shenzhen Langkun Technology Co., Ltd. with a registered capital of 10 million RMB [1] - The legal representative of the new company is Zhou Cunquan [1] - The business scope includes health consulting services, human genetic diagnosis and treatment technology development, artificial intelligence application system integration services, and various sales related to health and medical products [1] Group 2 - The company is classified under the national standard industry of scientific research and technical services, specifically in research and experimental development [1] - The registered address of the company is located in Longgang District, Shenzhen [1] - The company is structured as a limited liability company with a corporate sole proprietorship and has an operating period until February 12, 2026, with no fixed term thereafter [1]

Group 1 - The core point of the news is the establishment of Xiamen Taisengyuan Biopharmaceutical Co., Ltd., with a registered capital of 3.1 million RMB, fully owned by Xiamen Taisengyuan Cell Technology Research Institute Co., Ltd. [1][2] - The legal representative of the company is Liu Xiang, and it is classified under the scientific research and technical service industry, specifically in research and experimental development [2]. - The company's business scope includes drug production, wholesale and retail of drugs, cell technology research and application, human stem cell technology development, and various other technical services and health consulting services [1][2]. Group 2 - The company is located at No. 2036, Wengjiao West Road, Haicang District, Xiamen, in the Xiamen Biopharmaceutical Industry Park [2]. - The company is a limited liability company with a natural person investment or control, and its business term is set until February 12, 2026, with no fixed expiration [2].

Core Viewpoint - Shenzhen Hengyao New Energy Technology Research Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various new energy technologies and services [1] Group 1: Company Overview - The legal representative of the company is Zhou Wenbin [1] - The company is a limited liability entity with an operational period until February 11, 2026, with no fixed term thereafter [1] - The company is located in the Guangming District of Shenzhen, specifically at No. 8, Guangyuan Fourth Road, Dongkeng Community [1] Group 2: Shareholding Structure - Zhou Wenbin holds a 34% stake in the company [1] - Shenzhen Zichengxing New Energy Investment Co., Ltd. owns 24% [1] - Chen Shuihong holds 22% [1] - Xiamen Luopan Power Consulting Service Co., Ltd. and He Jianzhong each hold 10% [1] Group 3: Business Scope - The company’s business scope includes research and development in emerging energy technologies, resource recycling technologies, solar and wind power services, and energy storage services [1] - It also focuses on carbon reduction, carbon conversion, carbon capture, and carbon storage technology research [1] - Additional services include technical consulting, information system integration, big data services, AI application software development, and semiconductor device manufacturing [1]

Core Viewpoint - Hunan Chaoyuan Biotechnology Co., Ltd. has been established with a registered capital of 2 million RMB, focusing on various technology and health-related services [1] Company Overview - The legal representative of Hunan Chaoyuan Biotechnology Co., Ltd. is Zhang Yong [1] - The company is a limited liability company with natural person investment or control [1] - The business scope includes brand management, marketing planning, information technology consulting, biomedical technology services, and various research and development activities [1] Shareholding Structure - Hunan Yuanjia Pharmaceutical Co., Ltd. holds 51% of the shares [1] - Changsha Bangbangtang Pharmaceutical Co., Ltd. holds 35% of the shares [1] - Zhang Yong holds 14% of the shares [1] Business Activities - The company engages in a wide range of activities including sales of health food, cosmetics, daily necessities, and personal hygiene products [1] - It also provides technical services, development, consulting, and various internet sales [1] - The company is located in Changsha, Hunan Province, with a business duration until February 9, 2026, and no fixed term thereafter [1]

Core Viewpoint - Hunan Miaomeizi Agricultural Technology Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various agricultural and food-related services and products [1] Company Summary - The legal representative of Hunan Miaomeizi Agricultural Technology Co., Ltd. is Su Ya [1] - The company has a registered capital of 5 million RMB [1] - Major shareholders include Hunan Miaomeizi Food Co., Ltd. (88%), Hainan Tongdaxin Trading Co., Ltd. (8%), and two individuals holding 2% each [1] Business Scope - The company’s business activities include technology services, agricultural planting (vegetables, fruits, beans, grains), food management, primary agricultural product acquisition, and food processing [1] - It also engages in retail and wholesale of edible agricultural products, health food sales, internet sales (excluding licensed goods), and supply chain management services [1] - The company is involved in various other services such as property management, conference and exhibition services, and import-export activities [1] - Licensed activities include the manufacturing and sales of bean products, food production, food sales, catering services, and alcoholic beverage operations [1]

Company Overview - Songpan Huason Purple Shell Biotechnology Co., Ltd. has been established with a registered capital of 60 million RMB [1] - The legal representative is Liu Yangya, and the shareholders include Sichuan Xingcan Huaxiao Bei Biotechnology Co., Ltd. (51%) and Songpan County State-owned Assets Investment Management Co., Ltd. (49%) [1] Business Scope - The company engages in agricultural scientific research and experimental development, cell technology research and application, and various technical services including consulting and technology transfer [1] - Other activities include the cultivation and acquisition of traditional Chinese medicine, ecological environment material sales, and the development of composite microbial fertilizers and biopesticides [1] - The company also focuses on smart agricultural management, industrial internet data services, and crop pest control services [1] Regulatory Information - The company is registered under the category of scientific research and technical services, specifically in engineering and technology research and experimental development [1] - It is located in Songpan County, Aba Tibetan and Qiang Autonomous Prefecture, Sichuan Province, with an operational period until February 9, 2026, and no fixed term thereafter [1] - The business activities are subject to approval by relevant authorities, particularly for projects involving national key protected wild plants [1]